The U.S. Food and Drug Administration (FDA) did its best Tuesday to extend an olive branch to pharmacists who struggle to maneuver around its web site to find information from the Division of Drug Information (DDI).
The U.S. Food and Drug Administration (FDA) did its best Tuesdayto extend an olive branch to pharmacists who struggle to maneuveraround its web site to find information from the Division of DrugInformation (DDI).
Catherine Chew, PharmD, senior health promotion officer with theFDA's DDI, presented information and resources to about 50pharmacists Tuesday.
The DDI fields questions from healthcare professionals,consumers, and manufacturers, just to name a few, Dr. Chew said.And the number of telephone calls and e-mails received by theoffice has been increasing over the past few years, mostlybecause of legislative changes.
Many of the questions the office gets are about generic drugs andspecific drug usages, side effects, and dietary supplements, shesaid.
She also discussed some resources available through the DDI thatattendees may not have been aware of. Some of these resourcesinclude:
To learn more about the DDI, Chew recommended that pharmacistscontact the agency by e-mail at
druginfo@fda.hhs.gov
, byphone at the main
FDA
telephone number(
888-463-6332
) or at the
Drug Information
telephonenumber (
301-796-3400
) between the hours of 8:00 am and4:30 pm Monday through Friday, or by mail at:
Division of Drug Information
10903 New Hampshire Avenue
WO51-2201
Rockville, MD 20857.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.